Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- Check3 days agoChange DetectedThe page's revision indicator was updated to Revision: v3.6.5. Several legacy sponsor, collaborator, and study document references were removed, resulting in a leaner Study Details page while preserving essential trial information.SummaryDifference20%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's metadata. This reflects an update to the page's revision history rather than study content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the study record (likely QC or formatting adjustments) without substantive changes to the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page gains new study metadata and documentation, including sponsor and investigators, collaborators, and links to the Study Protocol and SAP, as well as IPD sharing information and related MeSH terms.SummaryDifference73%

- Check54 days agoChange DetectedNo additions or deletions were provided in the data, so there is no change to evaluate. The study details content remains as documented on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedThe Study Details page gains recruitment status and guidance sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0; the existing 'Intervention/Treatment' section is removed and the prior v3.5.5 revision note is eliminated.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.